2012
DOI: 10.3724/sp.j.1263.2012.05091
|View full text |Cite
|
Sign up to set email alerts
|

Clinical applications of fractional flow reserve in bifurcation lesions

Abstract: Percutaneous coronary intervention (PCI) for coronary bifurcation lesions has been associated with lower procedural success rates and worse clinical outcomes compared with PCI for simple coronary lesions. Angiographic evaluation alone is sometimes inaccurate and does not reflect the functional significance of bifurcation lesions. The fractional flow reserve (FFR) is an easily obtainable, reliable, and reproducible physiologic parameter. This parameter is epicardial lesion specific and reflects both degree of s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…The FFR is an accurate and lesion-specific index to indicate whether a stenosis is responsible for ischemia [ 9 ]. It has been well established that FFR is a reliable and feasible measurement tool of CAD, including angiographic intermediate stenosis, multi-vessel disease, left main coronary artery stenosis, and bifurcation lesions, and of significant benefit in guiding percutaneous coronary intervention (PCI) [ 5 , 6 , 10 13 ]. Thus, current guidelines recommend FFR as level of evidence ‘A’ when the ischemic potential for specific lesions is controversial [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…The FFR is an accurate and lesion-specific index to indicate whether a stenosis is responsible for ischemia [ 9 ]. It has been well established that FFR is a reliable and feasible measurement tool of CAD, including angiographic intermediate stenosis, multi-vessel disease, left main coronary artery stenosis, and bifurcation lesions, and of significant benefit in guiding percutaneous coronary intervention (PCI) [ 5 , 6 , 10 13 ]. Thus, current guidelines recommend FFR as level of evidence ‘A’ when the ischemic potential for specific lesions is controversial [ 14 ].…”
Section: Introductionmentioning
confidence: 99%